Bio-Rad's Q3 Revenues Drop 4 Percent on Currency Effects | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its third-quarter revenues slipped nearly 4 percent year over year largely due to the effects of currency translation.

The Hercules, Calif.-based life science research tools firm brought in total revenues of $498.7 million for the three months ended Sept. 30, compared to $516.5 million for the third quarter of 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.